Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioningALTHOF, S. E; TURNER, L. A; LEVINE, S. B et al.Journal of sex and marital therapy. 1987, Vol 13, Num 3, pp 155-167, issn 0092-623XArticle

Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotenceSIRAJ, Q. H; AKHTAR, M. A.Journal of the Pakistan Medical Association. 1987, Vol 39, Num 7, pp 172-176, issn 0030-9982, 5 p.Article

Clinical Outcomes of Intracavernosal Injection in Postprostatectomy Patients: A Single-center ExperienceDOMES, Trustin; CHUNG, Eric; LING DEYOUNG et al.Urology (Ridgewood, NJ). 2012, Vol 79, Num 1, pp 150-155, issn 0090-4295, 6 p.Article

AlprostadilLa Revue Prescrire. 1996, Vol 16, Num 165, pp 583-584, issn 0247-7750Article

Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined deliverySTIEF, C. G; WETTERAUER, U.The Journal of urology. 1988, Vol 140, Num 6, pp 1415-1416, issn 0022-5347Article

Studies on intracavernosal VIP levels during pharmacologically induced penile erectionsKYELY, E. A; BLANK, M. A; BLOOM, S. R et al.British journal of urology (Print). 1987, Vol 59, Num 4, pp 334-339, issn 0007-1331Article

Papaverine hydrochloride in peripheral blood and the degree of penile erectionTANAKA, T.The Journal of urology. 1990, Vol 143, Num 6, pp 1135-1137, issn 0022-5347Article

Moxisylyte plasma kinetics in humans after intracavernous administrationCOSTA, P; BRESSOLLE, F; SARRAZIN, B et al.Biopharmaceutics & drug disposition. 1992, Vol 13, Num 9, pp 671-679, issn 0142-2782Article

Pharmacologically induced penile erection (PIPE) as a maintenance treatment for erectile impotence : a report of 41 casesCROWE, M. J; QURESHI, M. J. H.Sexual and marital therapy. 1991, Vol 6, Num 3, pp 273-285, issn 0267-4653Article

Résultats préliminaires d'injections intracaverneuses d'un donneur d'oxyde d'azote (NO), la linsidomine, dans le traitement de l'impuissance = Preliminary results with the nitric oxyde (NO) donor sin1 in the treatment of human erectile dysfunctionSTIEF, C. G; HOLMQUIST, F; ANDERSSON, K. E et al.Andrologie. 1991, Vol 1, Num 2, pp 83-84Article

Intracavernous injection therapy : analysis of results and complicationsLAKIN, M. M; MONTAGUE, D. K; VANDERBRUG MENDENDORP, S et al.The Journal of urology. 1990, Vol 143, Num 6, pp 1138-1141, issn 0022-5347Article

Que peut-on réellement attendre des injections intracaverneuses de papavérine pour le diagnostic et le traitement de l'impuissance? Analyse des résultats de 310 injections pratiquées chez 100 patients = What are really the diagnostic and therapeutic possibilities of the intracavernous injections of papaverine in the impotent patients?BUVAT, J; LEMAIRE, A; MARCOLIN, G et al.Contraception fertilité sexualité (1973). 1987, Vol 15, Num 12, pp 1161-1170, issn 0301-861X, 8 p.Article

Intracavernous injection of papaverine in paraplegic malesBERETTA, G; ZANOLLO, A; FANCIULLACCI, F et al.Acta europaea fertilitatis. 1986, Vol 17, Num 4, pp 283-284, issn 0587-2421Article

Intracavernous prostaglandin E₁ in erectile dysfunctionLINET, O. I; NEFF, L. L.The Clinical investigator. 1994, Vol 72, Num 2, pp 139-149, issn 0941-0198Article

Erectile impotence and its managementWILLIAMS, G.Stress medicine. 1988, Vol 4, Num 2, pp 113-116, issn 0748-8386Article

Réflexions et incertitudes à propos des injections intracaverneuses de drogues vasoactives = Considerations and doubts about the intracavernous injection of vasoactive drugsDOREMIEUX, J; BONDIL, P.Cahiers de sexologie clinique. 1987, Vol 13, Num 77, pp 20-25, issn 0336-5913Article

Elimination of pain caused by small-carrion penile prosthesisKRAUSS, D. J.Urology (Ridgewood, NJ). 1987, pp 22-23, issn 0090-4295, UROTECHArticle

Grease-gun injury to the penisKALSI, J. S; ARYA, M; PETERS, J et al.Journal of the Royal Society of Medicine. 2002, Vol 95, Num 5, issn 0141-0768, p. 254Article

The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunctionPERIMENIS, P; ATHANASOPOULOS, A; GERAMOUTSOS, I et al.Urologia Internationalis. 2001, Vol 66, Num 1, pp 27-29, issn 0042-1138Article

Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunctionKUNELIUS, P; LUKKARINEN, O.International journal of impotence research. 1999, Vol 11, Num 1, pp 21-24, issn 0955-9930Article

Genital plus audiovisual sexual stimulation following intracavernous vasoactive injection versus re-dosing for erectile dysfunction: Results of a prospective studyMONTORSI, F; GUAZZONI, G; BARBIERI, L et al.The Journal of urology. 1998, Vol 159, Num 1, pp 113-115, issn 0022-5347Article

Penile shaft hypopigmentation : Lichen sclerosus occurring after the initiation of alprostadil intracavernous injections for erectile dysfunctionENGLISH, J. C; KING, D. H. C; FOLEY, J. P et al.Journal of the American Academy of Dermatology. 1998, Vol 39, Num 5, pp 801-803, issn 0190-9622, 1Article

Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunctionKAPLAN, S. A; REIS, R. B; KOHN, I. J et al.Urology (Ridgewood, NJ). 1998, Vol 52, Num 5, pp 739-743, issn 0090-4295Article

Import catheter in erectile dysfunctionKAYIGIL, O; ATAHAN, Ö; METIN, A et al.The Journal of urology. 1997, Vol 158, Num 2, pp 530-532, issn 0022-5347Article

Intracavernosal forskolin : Role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. Commentaries. Authors' replyMULHALL, J. P; DALLER, M; STEERS, W. D et al.The Journal of urology. 1997, Vol 158, Num 5, pp 1752-1759, issn 0022-5347Article